Ida De Luca

Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions

Lorena Incorvaia, Daniele Fanale, Giuseppe Badalamenti et al. · OncoImmunology · 2020 · 79 citations · Full text

Marginal donors in liver transplantation

Giuseppe Tisone, Tommaso Maria Manzia, Settimio Zazza et al. · Transplantation Proceedings · 2004 · 56 citations · Full text

Marginal Donors, Organ Donation, Transplantation +5

A “Lymphocyte MicroRNA Signature” as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming

Lorena Incorvaia, Daniele Fanale, Giuseppe Badalamenti et al. · Cancers · 2020 · 54 citations · Full text

Immunology, Immunotherapy, Immunotherapy Response +20

Type and Gene Location of KIT Mutations Predict Progression-Free Survival to First-Line Imatinib in Gastrointestinal Stromal Tumors: A Look into the Exon

Lorena Incorvaia, Daniele Fanale, Bruno Vincenzi et al. · Cancers · 2021 · 41 citations · Full text

Prognostic Role of Plasma PD-1, PD-L1, pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival?

Daniele Fanale, Lorena Incorvaia, Giuseppe Badalamenti et al. · Cancers · 2021 · 28 citations · Full text